Health Insurance Ilsan Hospital Joint Development Apollo Wins CES 2025 Innovation Award
Jan 10, 2025
National Health Insurance Ilsan Hospital won the Innovation Award at CES 2025, the world's largest IT exhibition, for its medical wearable device 'Apollon Apollo' (tentative name), which is being developed in collaboration with healthcare company Sky Labs.
The 'CES 2025 Innovation Award' is an award given by the National Consumer Technology Association (CTA), which is awarded to products recognized for their contribution to industrial development through innovative technologies and products.
Apollo is a medical device being developed by the National Health Insurance Ilsan Hospital as part of the national R&D task project selected in 2023, and is designed to monitor the health status of inpatients and home patients in real time.
The device operates in the form of a ring-shaped sensor and a wrist display connected, and can simultaneously measure six major biological signs such as blood pressure, pulse rate, respiratory rate, arrhythmia, body temperature, and oxygen saturation. The data collected through the wrist display is automatically transmitted to the medical staff in real time, allowing remote monitoring and simple communication to be smoothly performed regardless of time and place.
In addition, Apollo is being developed to reflect future hospital needs to efficiently perform health care tasks for a large number of inpatients and home patients. It helps medical staff focus on patient care and decision-making by automating repetitive nursing tasks while providing a more precise understanding of the patient's condition. Through this, it is expected to significantly improve the work efficiency and patient care quality in the medical field, as well as the effect of saving manpower, cost, and time.
Han Chang-hoon, director of the National Health Insurance Ilsan Hospital, said "It is very meaningful that Apollo will be awarded the Innovation Award at CES 2025""This product is a globally recognized case in which it is an innovative solution that simplifies the work of healthcare staff and improves the quality of patient care."" "We will continue to contribute to improving the quality of health care and leading the smart hospital system through continuous innovation and research and development."
The 'CES 2025 Innovation Award' is an award given by the National Consumer Technology Association (CTA), which is awarded to products recognized for their contribution to industrial development through innovative technologies and products.
Apollo is a medical device being developed by the National Health Insurance Ilsan Hospital as part of the national R&D task project selected in 2023, and is designed to monitor the health status of inpatients and home patients in real time.
The device operates in the form of a ring-shaped sensor and a wrist display connected, and can simultaneously measure six major biological signs such as blood pressure, pulse rate, respiratory rate, arrhythmia, body temperature, and oxygen saturation. The data collected through the wrist display is automatically transmitted to the medical staff in real time, allowing remote monitoring and simple communication to be smoothly performed regardless of time and place.
In addition, Apollo is being developed to reflect future hospital needs to efficiently perform health care tasks for a large number of inpatients and home patients. It helps medical staff focus on patient care and decision-making by automating repetitive nursing tasks while providing a more precise understanding of the patient's condition. Through this, it is expected to significantly improve the work efficiency and patient care quality in the medical field, as well as the effect of saving manpower, cost, and time.
Han Chang-hoon, director of the National Health Insurance Ilsan Hospital, said "It is very meaningful that Apollo will be awarded the Innovation Award at CES 2025""This product is a globally recognized case in which it is an innovative solution that simplifies the work of healthcare staff and improves the quality of patient care."" "We will continue to contribute to improving the quality of health care and leading the smart hospital system through continuous innovation and research and development."
|
This article was translated by Naver AI translator.
